BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Langers AM, Verspaget HW, Hommes DW, Sier CF. Single-nucleotide polymorphisms of matrix metalloproteinases and their inhibitors in gastrointestinal cancer. World J Gastrointest Oncol 2011; 3(6): 79-98 [PMID: 21731908 DOI: 10.4251/wjgo.v3.i6.79]
URL: https://www.wjgnet.com/1948-5204/full/v3/i6/79.htm
Number Citing Articles
1
A M J Langers, H W Verspaget, L J A C Hawinkels, F J G M Kubben, W van Duijn, J J van der Reijden, J C H Hardwick, D W Hommes, C F M Sier. MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patientsBritish Journal of Cancer 2012; 106(9): 1495 doi: 10.1038/bjc.2012.80
2
Virgilio Olsen, Luis E. Rohde, Luis Beck-da-Silva, Kátia G. Santos, Andréia Biolo, Nadine Clausell, Michael Andrades. QRS Widening Rates and Genetic Polymorphisms of Matrix Metalloproteinases in a Cohort of Patients With Chronic Heart FailureCanadian Journal of Cardiology 2014; 30(3): 345 doi: 10.1016/j.cjca.2013.11.014
3
Anita Barišić, Sanja Dević Pavlić, Saša Ostojić, Nina Pereza. Matrix metalloproteinase and tissue inhibitors of metalloproteinases gene polymorphisms in disorders that influence fertility and pregnancy complications: A systematic review and meta-analysisGene 2018; 647: 48 doi: 10.1016/j.gene.2018.01.010
4
Mujeeb Zafar Banday, Aga Syed Sameer, Ashaq Hussain Mir, Taseem A. Mokhdomi, Nissar A. Chowdri, Ehtishamul Haq. Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population — A case–control study and a mini reviewGene 2016; 589(1): 81 doi: 10.1016/j.gene.2016.05.028
5
Ulviye Göksen Arslan, Recep Özmerdivenli, Kürşat Oğuz Yaykaşlı, Murat Oktay, Havva Erdem, Hatice Soğuktaş, Emine Yaykaşlı. Investigation of TIMP2 Gene Polymorphisms Incidence in Patients with Breast CancerEuropean Journal of Basic Medical Sciences 2012; 2(4): 101 doi: 10.21601/ejbms/9188
6
Kousik Kesh, Lakshmi Subramanian, Nillu Ghosh, Vinayak Gupta, Arnab Gupta, Samir Bhattacharya, Nitish R. Mahapatra, Snehasikta Swarnakar. Association of MMP7 −181A→G Promoter Polymorphism with Gastric Cancer RiskJournal of Biological Chemistry 2015; 290(23): 14391 doi: 10.1074/jbc.M114.630129
7
Burcu Çaykara, Hani Alsaadoni, Sadrettin Pençe, Halime Hanım Pençe, Alper Ötünçtemur. Investigation of MMP-9 rs3918242 and TIMP-2 rs8179090 polymorphisms in renal cell carcinoma tissuesTurkish Journal of Biochemistry 2020; 45(4): 429 doi: 10.1515/tjb-2019-0048
8
Wen Li, Ming Jia, Jian Wang, Jie Lu, Jing Deng, Jian Tang, Cun Liu. Association of MMP9-1562C/T and MMP13-77A/G Polymorphisms with Non-Small Cell Lung Cancer in Southern Chinese PopulationBiomolecules 2019; 9(3): 107 doi: 10.3390/biom9030107
9
Mujeeb Zafar Banday, Aga Syed Sameer. Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population – a case control studyBioscience Reports 2019; 39(5) doi: 10.1042/BSR20190478
10
Zahra Pezeshkian, Stefania Nobili, Noshad Peyravian, Bahador Shojaee, Haniye Nazari, Hiva Soleimani, Hamid Asadzadeh-Aghdaei, Maziar Ashrafian Bonab, Ehsan Nazemalhosseini-Mojarad, Enrico Mini. Insights into the Role of Matrix Metalloproteinases in Precancerous Conditions and in Colorectal CancerCancers 2021; 13(24): 6226 doi: 10.3390/cancers13246226
11
Diego Sbardella, Giovanni Francesco Fasciglione, Magda Gioia, Chiara Ciaccio, Grazia Raffaella Tundo, Stefano Marini, Massimo Coletta. Human matrix metalloproteinases: An ubiquitarian class of enzymes involved in several pathological processesMolecular Aspects of Medicine 2012; 33(2): 119 doi: 10.1016/j.mam.2011.10.015
12
Felipe Rodrigues de Matos, Edilmar de Moura Santos, Hellen Bandeira de Pontes Santos, Renato Assis Machado, Telma Maria Araújo Moura Lemos, Ricardo D. Coletta, Roseana de Almeida Freitas. Association of polymorphisms in IL-8, MMP-1 and MMP-13 with the risk and prognosis of oral and oropharyngeal squamous cell carcinomaArchives of Oral Biology 2019; 108: 104547 doi: 10.1016/j.archoralbio.2019.104547
13
Ghislain Opdenakker, Séverine Vermeire, Ahmed Abu El-Asrar. How to place the duality of specific MMP-9 inhibition for treatment of inflammatory bowel diseases into clinical opportunities?Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.983964
14
Sylwia Pabian-Jewuła, Magdalena Ambrożek-Latecka, Aneta Brągiel-Pieczonka, Klaudia Nowicka, Marcin Rylski. Identification of Molecular Mechanisms Responsible for the MMP-9-1562C/T Dependent Differential Regulation of Matrix Metalloproteinase-9 Expression in Human Neuron-like CellsGenes 2023; 14(11): 2028 doi: 10.3390/genes14112028
15
László Herszényi, István Hritz, Gábor Lakatos, Mária Varga, Zsolt Tulassay. The Behavior of Matrix Metalloproteinases and Their Inhibitors in Colorectal CancerInternational Journal of Molecular Sciences 2012; 13(12): 13240 doi: 10.3390/ijms131013240
16
Magali de Bruyn, Jennifer Vandooren, Estefania Ugarte-Berzal, Ingrid Arijs, Séverine Vermeire, Ghislain Opdenakker. The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseasesCritical Reviews in Biochemistry and Molecular Biology 2016; 51(5): 295 doi: 10.1080/10409238.2016.1199535
17
Priyanka Srivastava, Rakesh Kapoor, Rama Devi Mittal. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohortGene 2013; 530(2): 273 doi: 10.1016/j.gene.2013.06.087
18
Sugreev Verma, Kousik Kesh, Arnab Gupta, Snehasikta Swarnakar. An Overview of Matrix Metalloproteinase 9 Polymorphism and Gastric Cancer RiskAsian Pacific Journal of Cancer Prevention 2015; 16(17): 7393 doi: 10.7314/APJCP.2015.16.17.7393